NCT03340571View on ClinicalTrials.gov

Blood Biomarker of Alzheimer's Disease (AD)

CompletedOBSERVATIONAL

Enrollment

21

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions

Alzheimer Disease

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT03340571 - Blood Biomarker of Alzheimer's Disease (AD) | Biotech Hunter | Biotech Hunter